Skip to content
Screener

Enanta Pharmaceuticals ENTA Q2 2026 earnings

Reported August 10, 2026 · After market close

Revenue$14.4MMiss by $2.4M
EPS-$0.67Miss by $0.16
Revenue estimate$16.8M
EPS estimate-$0.51

Next report

Nov 16, 2026 (in 2 months)
Revenue estimate$15.7M
EPS estimate-$0.77

FAQ

When did Enanta Pharmaceuticals report Q2 2026 earnings?
Enanta Pharmaceuticals (ENTA) reported Q2 2026 earnings on August 10, 2026 after market close.
What were Enanta Pharmaceuticals's Q2 2026 revenue and EPS?
Enanta Pharmaceuticals reported revenue of $14.4M and eps of $-0.67 for Q2 2026.
Did Enanta Pharmaceuticals beat estimates in Q2 2026?
Revenue missed the consensus estimate of $16.8M by $2.4M. EPS missed the consensus estimate of $-0.51 by $0.16.
How did Enanta Pharmaceuticals's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 21.6% from $18.3M a year earlier and eps grew 21.2% from $-0.85.
Where can I find Enanta Pharmaceuticals's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-342336) and the 10-Q periodic report (0001193125-26-345719) directly on SEC EDGAR. The filing index links above go to sec.gov.